Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3280853 | Arab Journal of Gastroenterology | 2014 | 5 Pages |
Abstract
The entecavir 1-mg monotherapy group achieved better HBV-DNA undetectability starting at 3Â months of treatment when compared to the Lam/Adv group; however, both lines of treatment showed almost similar results over the rest of the study period. HBeAg seroconversion was only achieved in two cases in the combined Lam/Adv group, whereas no cases lost HBeAg in the other group.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Sahar Maklad, Wahid Doss, Sameh Seif El Din, Kamal Hassan, Alaa Abou Zeid,